Juvenile idiopathic arthritis (JIA) is an umbrella term for arthritis of unknown origin, lasting
for> 6 weeks with onset before 16 years of age. JIA is the most common chronic …

Juvenile idiopathic arthritis (JIA), as a chronic condition, is associated with significant
disease-and treatment-related morbidity, thus impacting children's quality of life. In order to …

Objective To provide updated guidelines for pharmacologic management of juvenile
idiopathic arthritis (JIA), focusing on treatment of oligoarthritis, temporomandibular joint …

Recent therapeutic advances in juvenile idiopathic arthritis (JIA) have made remission an
achievable goal for most patients. Reaching this target leads to improved outcomes. The …

Background To our knowledge, the characteristics and burden of childhood arthritis have
never been studied on a worldwide basis. We aimed to investigate, with a cross-sectional …

Objectives To describe disease activity 30 years after disease onset in a previously studied
cohort of patients with juvenile idiopathic arthritis (JIA) and reveal predictors of long-term …

Objective To develop and validate new Juvenile Arthritis Disease Activity Score 10
(JADAS10) and clinical JADAS10 (cJADAS10) cutoffs to separate the states of inactive …

Objective To determine cutoff values for defining the states of inactive disease (ID), low
disease activity (LDA; or minimal disease activity), moderate disease activity (MDA), and …

Background Herein we describe the history, design, and rationale of the new Childhood
Arthritis and Rheumatology Research Alliance (CARRA) Registry and present the …

The treatment of juvenile idiopathic arthritis (JIA) is evolving. The growing number of
effective drugs has led to successful treatment and prevention of long-term sequelae in most …